These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 16304992)
1. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas. Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992 [TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814 [TBL] [Abstract][Full Text] [Related]
3. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Izban KF; Ergin M; Martinez RL; Alkan S Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929 [TBL] [Abstract][Full Text] [Related]
4. Human RPE expression of cell survival factors. Yang P; Wiser JL; Peairs JJ; Ebright JN; Zavodni ZJ; Bowes Rickman C; Jaffe GJ Invest Ophthalmol Vis Sci; 2005 May; 46(5):1755-64. PubMed ID: 15851579 [TBL] [Abstract][Full Text] [Related]
5. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells. Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595 [TBL] [Abstract][Full Text] [Related]
6. AWP1 binds to tumor necrosis factor receptor-associated factor 2 (TRAF2) and is involved in TRAF2-mediated nuclear factor-kappaB signaling. Chang EJ; Ha J; Kang SS; Lee ZH; Kim HH Int J Biochem Cell Biol; 2011 Nov; 43(11):1612-20. PubMed ID: 21810480 [TBL] [Abstract][Full Text] [Related]
7. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006 [TBL] [Abstract][Full Text] [Related]
8. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365 [TBL] [Abstract][Full Text] [Related]
9. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970 [TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. Henkler F; Baumann B; Fotin-Mleczek M; Weingärtner M; Schwenzer R; Peters N; Graness A; Wirth T; Scheurich P; Schmid JA; Wajant H J Biol Chem; 2003 Aug; 278(31):29216-30. PubMed ID: 12709429 [TBL] [Abstract][Full Text] [Related]
11. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling. Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex. Kim CM; Jeong JH; Son YJ; Choi JH; Kim S; Park HH FEBS Lett; 2017 Mar; 591(5):810-821. PubMed ID: 28155233 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of TNF-α in grass carp head kidney leukocytes: induction and involvement in the regulation of NF-κB signaling. Zhang A; Chen D; Wei H; Du L; Zhao T; Wang X; Zhou H Fish Shellfish Immunol; 2012 Nov; 33(5):1123-32. PubMed ID: 22981915 [TBL] [Abstract][Full Text] [Related]
15. Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling. Sughra K; Birbach A; de Martin R; Schmid JA PLoS One; 2010 Sep; 5(9):e12683. PubMed ID: 20856938 [TBL] [Abstract][Full Text] [Related]
16. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. Guasparri I; Wu H; Cesarman E EMBO Rep; 2006 Jan; 7(1):114-9. PubMed ID: 16311516 [TBL] [Abstract][Full Text] [Related]
17. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. Takeuchi M; Rothe M; Goeddel DV J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708 [TBL] [Abstract][Full Text] [Related]
19. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224 [TBL] [Abstract][Full Text] [Related]
20. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Song HY; Rothe M; Goeddel DV Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6721-5. PubMed ID: 8692885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]